Introducing CHOP OPEN!

We have launched our new and improved learning platform, CHOP OPEN. Learn more and register for free.

This seminar focuses on behavioral pediatrics and was delivered in Salzburg, Austria, from June 3 – 9, 2018. The lectures are prepared by staff from Children's Hospital of Philadelphia (CHOP) in weeklong modules that are prepared in affiliation with the American Austrian Foundation's Open Medical Institute. The lectures of this seminar are presented in the order of the live event.

Developmental & Behavioral Pediatrics

At the conclusion of this session, participants should be given an introduction to the educational goals of the behavioral pediatrics conference, as well as be given the opportunity to meet the speakers and the rest of the audience.

Principles of Developmental & Behavioral Pediatrics

At the conclusion of this session, participants should be able to describe the cultural perspective of childhood development and behavior, analyze the biological development and environment associated with children's learning, and discuss cognitive processes that can support or undermine learning.

Processes of Normal Development

At the conclusion of this session, participants should be able to define streams of development and interaction, report development benchmarks, and describe continuum of infant and early childhood development in motor, nonverbal cognition, communication/language, social emotional, and play skills.

Screening & Developmental Assessment

At the conclusion of this session, participants should be able to describe the benefits of developmental screening, report the impact of early identification and intervention, and discuss strategies for developmental surveillance and screening in clinical practice.

Behavior Difficulties & Management

At the conclusion of this session, participants should be able to discuss effective strategies for behavioral change and how to apply reinforcement, punishment, and extinction to aid in effecting behavioral change.

Case Presentations

At the conclusion of this session, participants should be able to discuss four clinical cases that involved developmental evaluations and diagnoses of pediatric patients.

Autism Spectrum Disorder

At the conclusion of this session, participants should be able to describe autism spectrum disorder (ASD) with respect to the associated clinical features, epidemiology, screenings for diagnosis, and current “standard” treatments.

Genetic Disorders & Developmental Disability

At the conclusion of this session, participants should be able to describe indications for genetic evaluations, identify the current genetic testing used, and discuss benefits and cautions of testing for genetic disorders.

Down Syndrome

At the conclusion of this session, participants should be able to describe the neurodevelopmental and behavioral complexity of trisomy 21 with respects to the genetics, the relationship of genotype to phenotype, and diagnostic plans and treatments for associated medical, emotional and behavioral problems in these pediatric patients.

Language & Learning Disorders

At the conclusion of this session, participants should be able to describe the definition and epidemiology of language and learning disorders, discuss milestone acquisition, and understand the evaluation and treatments for specific language impairment (SLI) and different types of learning disability (LD).

ADHD

At the conclusion of this session, participants should be able to describe the definition and epidemiology of attention deficit/hyperactivity disorder (ADHD), discuss the potential etiologies of ADHD, identify strategies for diagnoses, and list treatment modalities.

Developmental Delay & Intellectual Disability

At the conclusion of this session, participants should be able to describe the diagnostic criteria and diagnostic evaluation for intellectual disability, as well as identify the appropriate etiological evaluation for a child with intellectual disability.

Elimination Disorders

At the conclusion of this session, participants should be able to describe encopresis and enuresis with respect to the causes, evaluation, and management of these elimination disorders.

Motor Disabilities & Cerebral Palsy

At the conclusion of this session, participants should be able to define cerebral palsy with respect to its prevalence, clinical types and features, etiological factors, associated conditions, and treatments.

Prematurity: Impact on Development & Behavior

At the conclusion of this session, participants should be able to describe the epidemiology of prematurity and its sequelae, discuss factors associated with adverse outcomes, and identify types of developmental disabilities seen in former premature infants.

Sleep Disturbances

At the conclusion of this session, participants should be able to describe basic physiology of sleep and its relation to sleep problems, discuss the evaluation of a child with sleep problems, and understand behavioral interventions for common sleep problems.

Non-Traditional Treatments

At the conclusion of this session, participants should be able to define alternative medical (CAM) treatments, identify what clinicians need to know to counsel families on the use of CAM, and discuss evidence for efficacy and potential harm of selected CAM treatments in several types of disability.

Psychopharmacological Management

At the conclusion of this session, participants should be able to describe goals and indications for pharmacotherapy in individuals with developmental disabilities, discuss principles of treatment, and identify target behaviors and potential medications.

Vision and Hearing Loss

At the conclusion of this session, participants should be able to discuss the risk factors and conditions associated with visual impairment, as well as causes, risk factors, and evaluation strategies for hearing impairment in pediatric patients.

Quality Improvement & Family Partnership

At the conclusion of this session, participants should be able to summarize methods and goals of quality improvement (QI), identify the use and implementation of QI tools to improve clinical care, and describe the process and advantages of partnering with families using principles of shared decision making (SDM).